As over 200 companies compete to unveil the first successful covid-19 vaccine. Now the main issue of concern is if the vaccine has unexpected side effects then who would foot the bill in poor countries. Watch report.

Who will be liable for vaccine side effects? Question on financial claims still uncovered | COVID-19 Pandemic

The researchers said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55.

COVID-19 Oxford vaccine phase 1 & 2 trails successful: Trails were conducted on 1077 people

Moscow’s Sechenov University has completed tests on volunteers of the world’s first vaccine against COVID-19. The Russian embassy in India tweeted. “Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against #COVID19. The #vaccine is safe. The volunteers will be discharged on July 15 and July 20,” chief researcher Elena Smolyarchuk told TASS".

Russia's Sechenov University claims making vaccine against COVID-19

The first healthy volunteer has received a coronavirus vaccine developed by Imperial College London researchers. Imperial College London's vaccine candidate is being developed and trialed as part of 41 million pounds in funding from the UK government and a further 5 million pounds in philanthropic donations. Watch report.

Coronavirus Pandemic: 1st volunteer gets imperial COVID-19 vaccine

A Covid-19 vaccine that the Trump administration hopes will be available by January may not be equally effective for everyone, US officials said on Tuesday. But, they added, they expect as many as 40 million Americans to have developed coronavirus antibodies by the end of this year, which would lower the population that would need the treatment that officials hope will end the pandemic.

12 per cent of Americans may not need coronavirus vaccine: US officials

As the world comes to grips with the coronavirus pandemic the country's invest money and resources to push for a vaccine. Germany has taken a 23% stake in a private company and the company is called CureVac. Watch report.

Global race for Coronavirus vaccine: Germany buys 23% stake in CureVac

Desperation for a way to keep economies from collapsing under the weight of Covid-19 could mean settling for a vaccine that prevents people from getting really sick or dying but doesn't stop them from catching the coronavirus.

Initial COVID-19 vaccines may not prevent people from getting coronavirus

The coronavirus has affected even the mightiest countries of the world taking the global death toll to 48,276. Now according to some US researchers, there may be a ray of hope. BCG vaccine may offer protection against the deadly coronavirus. Watch report:

India's battle against COVID-19 Pandemic: BCG vaccine to offer COVID-19 protection

The German medicine firm is developing a possible vaccine for the 'pandemic' Coronavirus (COVID-19). After which, US President Donald Trump has been accused to monopolise that COVID-19 vaccine only for the US.

US President Trump accused to secure 'COVID-19' vaccine only for U.S.